Int J Biol Sci
2019; 15(3):610-616.
doi:10.7150/ijbs.29599 This issueCite
Review
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
Rosa Divella1, Antonio Mazzocca2, Antonella Daniele1, Carlo Sabbà2, Angelo Paradiso3✉
1. Department of Clinical Pathology Laboratory. IRCCS - Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco 65, 70124 Bari, Italy 2. Interdisciplinary Department of Medicine, University of Bari School of Medicine, Piazza G. Cesare, 11, 70124 Bari, Italy 3. Experimental Medical Oncology, IRCCS - Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco 65, 70124 Bari, Italy
✉ Corresponding author: Rosa Divella, Ph.D., Department of Clinical Pathology Laboratory. IRCCS - Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco 65, 70124 Bari, Italy. Tel. +39 805555259; E-mail: rosadiveit
Citation:
Divella R, Mazzocca A, Daniele A, Sabbà C, Paradiso A. Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. Int J Biol Sci 2019; 15(3):610-616. doi:10.7150/ijbs.29599. https://www.ijbs.com/v15p0610.htm
Western populations are becoming increasingly sedentary and the incidence of nonalcoholic fatty liver disease (NAFLD) is increasing and becoming one of the most common causes of liver disease worldwide. Also, NAFLD is considered one the new emerging risk factors for development of tumors of the gastro-intestinal tract, particularly hepatocellular carcinoma (HCC). Visceral obesity is an important risk factor for the onset of NAFLD. An accumulation of ectopic fat, including visceral obesity and fatty liver leads to a dysfunction of the adipose tissue with impaired production of adipocytokines which, in turn, favor an increase in pro-inflammatory cytokines. In this review, we discuss how the obesity-related chronic state of low-grade inflammation and the presence of NAFLD lead to the emergence of a microenvironment favorable to the development of cancer.
Keywords: NAFLD, adipocytokines, inflammation, obesity, cancer
Citation styles
APA
Divella, R., Mazzocca, A., Daniele, A., Sabbà, C., Paradiso, A. (2019). Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. International Journal of Biological Sciences, 15(3), 610-616. https://doi.org/10.7150/ijbs.29599.
ACS
Divella, R.; Mazzocca, A.; Daniele, A.; Sabbà, C.; Paradiso, A. Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. Int. J. Biol. Sci. 2019, 15 (3), 610-616. DOI: 10.7150/ijbs.29599.
NLM
Divella R, Mazzocca A, Daniele A, Sabbà C, Paradiso A. Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. Int J Biol Sci 2019; 15(3):610-616. doi:10.7150/ijbs.29599. https://www.ijbs.com/v15p0610.htm
CSE
Divella R, Mazzocca A, Daniele A, Sabbà C, Paradiso A. 2019. Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. Int J Biol Sci. 15(3):610-616.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.